Humaidan P - Search Results

1

Lutropin alfa: a viewpoint by Peter Humaidan.

Humaidan P. Humaidan P. Drugs. 2008;68(11):1541. doi: 10.2165/00003495-200868110-00006. Drugs. 2008. PMID: 18627211 No abstract available.

2

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.

Humaidan P, Chin W, Rogoff D, D'Hooghe T, Longobardi S, Hubbard J, Schertz J; ESPART Study Investigators‡. Humaidan P, et al. Hum Reprod. 2017 Mar 1;32(3):544-555. doi: 10.1093/humrep/dew360. Hum Reprod. 2017. PMID: 28137754 Free PMC article. Clinical Trial.

3

Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study.

Humaidan P, Bungum M, Bungum L, Yding Andersen C. Humaidan P, et al. Reprod Biomed Online. 2004 Jun;8(6):635-43. doi: 10.1016/s1472-6483(10)61643-4. Reprod Biomed Online. 2004. PMID: 15169576 Clinical Trial.

4

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.

Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY. Humaidan P, et al. Hum Reprod. 2005 May;20(5):1213-20. doi: 10.1093/humrep/deh765. Epub 2005 Mar 10. Hum Reprod. 2005. PMID: 15760966 Clinical Trial.

5

Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol.

Humaidan P, Bungum L, Bungum M, Hald F, Agerholm I, Blaabjerg J, Yding Andersen C, Lindenberg S. Humaidan P, et al. Reprod Biomed Online. 2005 Dec;11(6):679-84. doi: 10.1016/s1472-6483(10)61685-9. Reprod Biomed Online. 2005. PMID: 16417730 Clinical Trial.

6

To add or not to add LH: comments on a recent commentary.

Humaidan P. Humaidan P. Reprod Biomed Online. 2006 Mar;12(3):284-5. doi: 10.1016/s1472-6483(10)60998-4. Reprod Biomed Online. 2006. PMID: 16569311

7

Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study.

Humaidan P, Bungum L, Bungum M, Yding Andersen C. Humaidan P, et al. Reprod Biomed Online. 2006 Aug;13(2):173-8. doi: 10.1016/s1472-6483(10)60612-8. Reprod Biomed Online. 2006. PMID: 16895629 Clinical Trial.

8

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.

Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C. Humaidan P, et al. Fertil Steril. 2010 Feb;93(3):847-54. doi: 10.1016/j.fertnstert.2008.12.042. Epub 2009 Feb 6. Fertil Steril. 2010. PMID: 19200959 Free article. Clinical Trial.

9

GnRHa to trigger final oocyte maturation: a time to reconsider.

Humaidan P, Papanikolaou EG, Tarlatzis BC. Humaidan P, et al. Hum Reprod. 2009 Oct;24(10):2389-94. doi: 10.1093/humrep/dep246. Epub 2009 Jul 16. Hum Reprod. 2009. PMID: 19608565 Review.

10

Agonist trigger: what is the best approach? Agonist trigger and low dose hCG.

Humaidan P. Humaidan P. Fertil Steril. 2012 Mar;97(3):529-30. doi: 10.1016/j.fertnstert.2011.11.016. Epub 2011 Dec 9. Fertil Steril. 2012. PMID: 22154368 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page